Dietary olive oil supplemented with fish oil, rich in EPA and DHA (n-3) polyunsaturated fatty acids, attenuates colonic inflammation in rats with DSS-induced colitis

Journal of Nutrition

Volumn 135, Issue 4, 2005, Pages 687-694

  Camuesco, Desirée ^a   Gálvez, Julio ^a   Nieto, Ana ^b   Comalada, Mònica ^a   Rodríguez Cabezas, M Elena ^a   Concha, Angel ^c   Xaus, Jordi ^d   Zarzuelo, Antonio ^a  

^a UNIVERSITY OF GRANADA   (Spain)

^b Health and Progress Foundation   (Spain)

^c HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^d Puleva Biotech SA   (Spain)

Author keywords

(n 3) polyunsaturated fatty acid; Leukotriene B4; Nitric oxide synthase; Rat experimental colitis; Tumor necrosis factor

Indexed keywords

GLUTATHIONE; LEUKOTRIENE B4; NITRIC OXIDE; OLIVE OIL; OMEGA 3 FATTY ACID; SODIUM SULFATE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLITIS; COLON; CONTROLLED STUDY; DIET; DIETARY INTAKE; EVALUATION; FEMALE; INFLAMMATION; NONHUMAN; RAT; SOYBEAN;

GLYCINE MAX;

EID: 16244405611     PISSN: 00223166     EISSN: None     Source Type: Journal    
DOI: 10.1093/jn/135.4.687     Document Type: Article

References (53)

1. Fiocchi, C. (1998) Inflammatory bowel disease: aetiology and pathogenesis. Gastroenterology 115: 182-205.
2. Sartor, R. B. (1997) Pathogenesis and immune mechanisms of chronic inflammatory bowel diseases. Am. J. Gastroenterol. 92 (suppl.): 5S-11S.
3. Kho, Y. H., Pool, M. O., Jansman, F. G. & Harting, J. W. (2001) Pharmacotherapeutic options in inflammatory bowel disease: an update. Pharm. World Sci. 23: 17-21.
4. Travis, S.P.L & Jewel, D. P. (1994) Salicylates for ulcerative colitis-their mode of action. Pharmacol. Ther. 63: 135-161.
5. Bratts, R. & Linden, M. (1996) Cytokine modulation by glucocorticoids: mechanisms and actions in cellular studies. Aliment. Pharmacol. Ther. 10: 81-90.
6. Enns, R. & Sutherland, L. (1998) Adverse events of medical therapy for treatment for inflammatory bowel disease. In: Clinical Challenges in Inflammatory Bowel Disease. Diagnosis, Prognosis and Treatment (Campieri, M., Bianchi-Porro, G., Fiocchi, C. & Schölmerich, J., eds.), pp. 113-123. Kluwer Academic Publishers, London, UK.
7. Stein, R. B. & Hanauer, S. B. (2000) Comparative tolerability of treatments for inflammatory bowel disease. Drug Saf. 23: 429-448.
8. Belluzzi, A., Boschi, S., Brignola, C., Munarini, A., Cariani, G. & Miglio, F. (2000) Polyunsaturated fatty acids and inflammatory bowel disease. Am. J. Clin. Nutr. 71: 339S-342S.
9. Siguel, E. N. & Lerman, R. H. (1996) Prevalence of essential fatty acid deficiency in patients with chronic gastrointestinal disorders. Metabolism 45: 12-23.
10. Gil, A. (2002) Polyunsaturated fatty acids and inflammatory diseases. Biomed. Pharmacother. 56: 388-393.
11. Campos, F. G., Waitzberg, D. L., Habr-Gama, A., Logullo, A. F., Noronha, I. L., Jancar, S., Torrinhas, R. S. & Fust, P. (2002) Impact of parenteral n-3 fatty acids on experimental acute colitis. Br. J. Nutr. 87 (suppl. 1): S83-S88.
12. Nieto, N., Torres, M. I., Rios, A. & Gil, A. (2002) Dietary polyunsaturated fatty acids improve histological and biochemical alterations in rats with experimental ulcerative colitis. J. Nutr. 132: 11-19.
13. Yuceyar, H., Ozutemiz, O., Huseyinov, A., Saruc, M., Alkanat, M., Bor, S., Coker, I. & Batur, Y. (1999) Is administration of n-3 fatty acids by mucosal enema protective against trinitrobenzene-induced colitis in rats? Prostaglandins Leukot. Essent. Fatty Acids 61: 339-345.
14. Andoh, A., Tsujikawa, T., Ishizuka, I., Araki, Y., Sasaki, M., Koyama, S. & Fujiyama, Y. (2003) n-3 Fatty acid-rich diet prevents early response of interleukin-6 elevation in trinitrobenzene sulfonic acid-induced enteritis. Int. J. Mol. Med. 12: 721-725.
15. Shimizu, T., Igarashi, J., Ohtuka, Y., Oguchi, S., Kaneko, K. & Yamashiro, Y. (2001) Effects of n-3 polyunsaturated fatty acids and vitamin E on colonic mucosal leukotriene generation, lipid peroxidation, and microcirculation in rats with experimental colitis. Digestion 63: 49-54.
16. 4 production in children with ulcerative colitis. J. Pediatr. Gastroenterol. Nutr. 37: 581-585.
17. Kubes, P., Grisham, M. B., Barrowman, J. A., Gaginella, T. & Granger, D. N. (1991) Leukocyte-induced vascular protein leakage in cat mesentery. Am. J. Physiol. 261: H1872-H1879.
18. Sharon, P. & Stenson, W. F. (1984) Enhanced synthesis of leukotriene B by colonic mucosa in inflammatory bowel disease. Gastroenterology 86: 453-460.
19. Almallah, Y. Z., Ewen, S. W., El-Tahir, A., Mowat, N.A.G., Brunt, P. W., Sinclair, T. S., Heys, T. S. & Eremin, O. (2000) Distal practocolitis and n-3 polyunsaturated fatty acids (n-3 PUFAs): the mucosal effect in situ. J. Clin. Immunol. 20: 68-76.
20. Purasiri, P., Murray, A., Richardson, S., Heys, S. D., Horrobin, D. & Eremin, O. (1994) Modulation of cytokine production in vivo by dietary essential fatty acids in patients with colorectal cancer. Clin. Sci. (Lond.) 87: 711-717.
21. Owen, R. W., Giacosa, A., Hull, W. E., Haubner, R., Wurtele, G., Spiegelhalder, B. & Bartsch, H. (2000) Olive-oil consumption and health: the possible role of antioxidants. Lancet Oncol. 1: 107-112.
22. Stark, A. H. & Madar, Z. (2002) Olive oil as a functional food: epidemiology and nutritional approaches. Nutr. Rev. 60: 170-176.
23. Alzoghaibi, M. A., Walsh, S. W., Willey, A., Fowler, A. A., 3rd & Graham, M. F. (2003) Linoleic acid, but not oleic acid, upregulates the production of interleukin-8 by human intestinal smooth muscle cells isolated from patients with Crohn's disease. Clin. Nutr. 22: 529-535.
24. Gaudio, E., Taddei, G., Vetuschi, A., Sferra, R., Frieri, G., Ricciardi, G. & Caprilli, R. (1999) Dextran sulfate sodium (DSS) colitis in rats: clinical, structural, and ultrastructural aspects. Dig. Dis. Sci. 44: 1458-1475.
25. Kulimann, F., Messmann, H., Alt, M., Gross, V., Bocker, T., Scholmerich, J. & Ruschoff, J. (2001) Clinical and histopathological features of dextran Sulfate sodium induced acute and chronic colitis associated with dysplasia in rats. Int. J. Colorectal Dis. 16: 238-246.
26. Stucchi, A. F., Shofer, S., Leeman, S., Materne, O., Beer, E., McClung, J., Shebani, K., Moore, F., O'Brien, M. & Becker, J. M. (2000) NK-1 antagonist reduces colonic inflammation and oxidative stress in dextran sulfate-induced colitis in rats. Am. J. Physiol. 279: G1298-G1306.
27. Cooper, H. S., Murthy, S. N., Shah, R. S. & Sedergran, D. J. (1993) Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab. Investig. 69: 238-249.
28. Krawisz, J. E., Sharon, P. & Stenson, W. F. (1984) Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology 87: 1344-1350.
29. Camuesco, D., Comalada, M., Rodriguez-Cabezas, M. E., Nieto, A., Lorente, M. D., Concha, A., Zarzuelo, A. & Galvez, J. (2004) The intestinal anti-inflammatory effect of quercitrin is associated with an inhibition in iNOS expression. Br. J. Pharmacol. 143: 908-918.
30. Anderson, M. E. (1985) Determination of glutathione and glutathione disulfide in biological samples. Methods Enzymol. 113: 548-555.
31. Lepage, G. & Roy, C. C. (1986) Direct transesterification of all classes of lipids in a one-step reaction. J. Lipid Res. 27: 114-120.
32. Harris, W. S. (1989) Fish oils and plasma lipid and lipoprotein metabolism in humans: a critical review. J. Lipid Res. 30: 785-807.
33. Bonna, K. H., Bjerve, K. S., Straume, B., Gram, I. T. & Thelle, D. (1990) Effects of eicosapentaenoic and docosahexaenoic acids on blood pressure in hypertension. A population-based intervention trial from the Tromso study. N. Engl. J. Med. 322: 795-801.
34. Beck, S. A., Smith, K. L. & Tisdale, M. J. (1991) Anticachectic and antitumor effect of eicosapentaenoic acid and its effect on protein turnover. Cancer Res. 51: 6089-6093.
35. Robinson, D. R., Xu, L. L., Tatenom, S., Guo, M. & Colvin, R. B. (1993) Suppression of autoimmune disease by dietary n-3 fatty acids. J. Lipid Res. 34: 1435-1444.
36. Arrington, J. L., McMurray, D. N., Switzer, K. C., Fan, Y. & Chapkin, R. S. (2001) Docosahexaenoic acid suppress function of the CD28 costimulatory membrane receptor in primary murine and Jurkat T Cells. J. Nutr. 131: 1147-1153.
37. Veljaca, M., Lesch, C. A., Pllana, R., Sanchez, B., Chan, K. & Guglietta, A. (1995) BPC-15 reduces trinitrobenzene sulfonic acid-induced colonic damage in rats. J. Pharmacol. Exp. Ther. 272: 417-422.
38. Galvez, J., Cruz, T., Crespo, E., Ocete, M. A., Lorente, M. D., Sanchez de Medina, F. & Zarzuelo, A. (1997) Rutoside as mucosal protective in acetic acid-induced rat colitis. Planta Med. 63: 409-414.
39. Calder, P. C. (2003) n-3 Polyunsaturated fatty acids and inflammation: from molecular biology to the clinic. Lipids 38: 343-352.
40. Harris, M. L., Schiller, H. J., Reilly, P. M., Donowitz, M., Grisham, M. B. & Bulkley, G. B. (1992) Free radicals and other reactive oxygen metabolites in inflammatory bowel disease: cause, consequence or epiphenomenon? Pharmacol. Ther. 53: 375-408.
41. Yamada, T. & Grisham, M. B. (1994) Pathogenesis of tissue injury: role of reactive metabolites of oxygen and nitrogen. In: Inflammatory Bowel Disease: From Bench to Bedside (Targan, S. R. & Shanahan, F., eds.), pp. 133-150. Williams & Wilkins, Baltimore, MD.
42. Rodriguez-Cabezas, M. E., Galvez, J., Lorente, M. D., Concha, A., Camuesco, D., Azzouzz, S., Osuna, A., Redondo, L. & Zarzuelo, A. (2002) Dietary fiber down-regulates tumor necrosis factor α and nitric oxide production in trinitrobenzenesulfonic acid-induced colitic rats. J. Nutr. 132: 3263-3271.
43. Lih-Brody, L., Powell, S. R., Collier, K. P., Reddy, G. M., Cerchia, R., Kahn, E., Weissman, G. S., Katz, S., Floyd, R. A., McKinley, M. J., Fisher, S. E. & Mullin, G. E. (1996) Increased oxidative stress and decreased antioxidant defences in mucosa of inflammatory bowel disease, Dig. Dis. Sci. 41: 2078-2086.
44. Grisham, M. B., Pavlick, K. P., Laroux, F. S., Hoffman, J., Bharwani, S. & Wolf, R. E. (2002) Nitric oxide and chronic gut inflammation: controversies in inflammatory bowel disease. J. Investig. Med. 50: 272-283.
45. Barbosa, D. S., Cecchini, R., El Kadri, M. Z., Rodriguez, M. A., Burini, R. C. & Dichi, I. (2003) Decreased oxidative stress in patients with ulcerative colitis supplemented with fish oil omega-3 fatty acids. Nutrition 19: 837-842.
46. Hecker, M., Preiss, C., Klemm, P. & Busse, R. (1996) Inhibition by antioxidants of nitric oxide synthase expression in murine macrophages: role of nuclear factor kappa B and interferon regulatory factor 1. Br. J. Pharmacol. 118: 2178-2184.
47. Yamada, N., Shimizu, J., Wada, M., Takita, T. & Innami, S. (1998) Changes in platelet aggregation and lipid metabolism in rats given dietary lipids containing different n-3 polyunsaturated fatty acids. J. Nutr. Sci. Vitaminol. 44: 279-89.
48. Stenson, W. F., Cort, D., Rodgers, J., Burakoff, R., DeSchryver- Kecskemeti, K., Gramlich, T. L. & Beeken, W. (1992) Dietary supplementation with fish oil in ulcerative colitis. Ann. Intern. Med. 116: 609-614.
49. Foell, D., Kucharzik, T., Kraft, M., Vogl, T., Sorg, C., Domschke, W. & Roth, J. (2003) Neutrophil derived human S100A12 (EN-RAGE) is strongly expressed during chronic active inflammatory bowel disease. Gut 52: 847-853.
50. Woywodt, A., Ludwig, D., Neustock, P., Kruse, A., Schwarting, K., Jantschek, G., Kirchner, H. & Stange, E. F. (1999) Mucosal cytokine expression, cellular markers and adhesion molecules in inflammatory bowel disease. Eur. J. Gastroenterol. Hepatol. 11: 267-276.
51. Novak, T. E., Babcock, T. A., Jho, D. H., Helton, W. S. & Espat, N. J. (2003) NF-kappa B inhibition by omega-3 fatty acids modulates LPS-stimulated macrophage TNF-alpha transcription. Am. J. Physiol. 284: L84-L89.
52. Baldwin, A. S., Jr. (1996) the NF-κB and κB proteins: new discoveries and insights. Annu. Rev. Immunol. 14: 649-683.
53. Xie, Q. W., Kashiwabara, Y. & Nathan, C. (1994) Role of transcription factor NF-κB/Rel in induction of nitric oxide synthase. J. Biol. Chem. 269: 4705-4708.